CD44+CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma

Cancer Biology and Therapy

Volumn 10, Issue 11, 2010, Pages 1182-1190

  Shi, Chengjian ^a   Tian, Rui ^a   Wang, Min ^a   Wang, Xin ^a   Jiang, Jianxin ^b   Zhang, Zhifa ^a   Li, Xu ^a   He, Zheng ^a   Gong, Weiqiang ^a   Qin, Renyi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

ABCG2; Cancer stem cell; CD133; CD44; Gallbladder carcinoma; Gli1; Tumorigenicity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; HERMES ANTIGEN; TRANSCRIPTION FACTOR GLI1; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE; GLI PROTEIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; ONCOPROTEIN; PEPTIDE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL POPULATION; CELL RENEWAL; COLONY FORMING CELL; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FLOW CYTOMETRY; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; DRUG RESISTANCE; GALLBLADDER TUMOR; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CELL LINE, TUMOR; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GALLBLADDER NEOPLASMS; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS; PEPTIDES; SPHEROIDS, CELLULAR; TRANS-ACTIVATORS; UP-REGULATION;

EID: 78649875907     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.11.13664     Document Type: Article

References (37)

1. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 2007; 11:671-81.
2. Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 2001; 21:295-314.
3. Roa I, de Aretxabala X, Araya JC, Villaseca M, Roa J, Guzman P. [Incipient gallbladder carcinoma. Clinical and pathological study and prognosis in 196 cases]. Rev Med Chil 2001; 129:1113-20.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414:105-11.
5. Scadden DT. Cancer stem cells refined. Nat Immunol 2004; 5:701-3.
6. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006; 66:1883-90.
7. O'Brien CA, Kreso A, Dick JE. Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009; 19:71-7.
8. Milas L, Hittelman WN. Cancer stem cells and tumor response to therapy: current problems and future prospects. Semin Radiat Oncol 2009; 19:96-105.
9. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3:730-7.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-8.
11. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-8.
12. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65:10946-51. (Pubitemid 41713363)
13. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67:1030-7. (Pubitemid 46270758)
14. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68:4311-20.
15. Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, et al. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 2009; 69:1776-81.
16. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66:9339-44.
17. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18:460-6.
18. Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells - old concepts, new insights. Cell Death Differ 2008; 15:947-58. (Pubitemid 351712600)
19. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007; 7:659-72. (Pubitemid 47327411)
20. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27:1006-20.
21. + population in hepatocellular carcinoma. Int J Cancer 2010; 126:2067-78.
22. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92:1295-302. (Pubitemid 30662093)
23. Bram EE, Stark M, Raz S, Assaraf YG. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance. Neoplasia 2009; 11:1359-70.
24. Ruiz IAA. The works of GLI and the power of hedgehog. Nat Cell Biol 1999; 1:147-8.
25. Ruiz IAA, Palma V, Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci 2002; 3:24-33.
26. Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA 2007; 104:5895-900.
27. Matise MP, Joyner AL. Gli genes in development and cancer. Oncogene 1999; 18:7852-9.
28. Ruiz IAA, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002; 2:361-72. (Pubitemid 37328949)
29. Asaoka Y, Kanai F, Ichimura T, Tateishi K, Tanaka Y, Ohta M, et al. Identification of a suppressive mechanism for Hedgehog signaling through a novel interaction of Gli with 14-3-3. J Biol Chem 2010; 285:4185-94.
30. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67:4827-33.
31. Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol Vis 2005; 11:729-37.
32. Ding XW, Wu JH, Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci 2010; 86:631-7.
33. Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009; 16:633-47.
34. Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells and senescence regulation. J Clin Invest 2004; 113:175-9.
35. Lie DC, Colamarino SA, Song HJ, Desire L, Mira H, Consiglio A, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005; 437:1370-5.
36. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458:776-9.
37. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008; 15:801-12.